Pages that link to "Q71613803"

The following pages link to Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction (Q71613803):

Displaying 24 items.

• How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial (Q24793341) (← links)
• Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease (Q28077454) (← links)
• The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data (Q30664916) (← links)
• ACE inhibition in aortic stenosis: dangerous medicine or golden opportunity? (Q34405412) (← links)
• Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. (Q34423315) (← links)
• Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study. (Q34695637) (← links)
• Genetic models provide unique insight into angiotensin and bradykinin peptides in the extravascular compartment of the heart in vivo (Q35125969) (← links)
• Association of common variations on chromosome 4q25 and left atrial volume in patients with atrial fibrillation (Q35605837) (← links)
• Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implications (Q35636401) (← links)
• Angiotensin-(1-7)-mediated signaling in cardiomyocytes. (Q35829928) (← links)
• Rethinking the renin-angiotensin system and its role in cardiovascular regulation. (Q36121970) (← links)
• Cardiovascular effects of losartan and its relevant clinical application (Q37595599) (← links)
• Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction (Q41104013) (← links)
• Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance (Q41682196) (← links)
• Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease (Q42554373) (← links)
• Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril (Q42869886) (← links)
• Effects of perindopril on aldosterone production in the failing human heart (Q43991539) (← links)
• Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril (Q46415630) (← links)
• Should we aim at tissue renin-angiotensin systems? (Q47998131) (← links)
• Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. (Q52965082) (← links)
• Cardiac angiotensin-converting enzyme activity in myocardial infarction (Q73065012) (← links)
• Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction (Q73407476) (← links)
• The necessary role of the autopsy in cardiovascular epidemiology (Q77726717) (← links)
• Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement (Q96302226) (← links)